Ryvu Therapeutics S.A. (WSE:RVU)
Poland
· Delayed Price · Currency is PLN 30.50
+0.20 (0.66%)
Aug 14, 2025, 4:45 PM CET
Ryvu Therapeutics Market Cap
Ryvu Therapeutics has a market cap or net worth of 700.54 million as of August 14, 2025. Its market cap has decreased by -38.91% in one year.
Market Cap
700.54M
Enterprise Value
614.66M
Revenue
97.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.50
Market Cap Chart
Since July 14, 2011, Ryvu Therapeutics's market cap has increased from 56.50M to 700.54M, an increase of 1,139.82%. That is a compound annual growth rate of 19.56%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.59B |
| NEUCA | 2.93B |
| Voxel | 1.88B |
| Synektik Spólka Akcyjna | 1.81B |
| Celon Pharma | 1.22B |
| Selvita | 607.57M |
| Centrum Medyczne ENEL-MED | 559.95M |
| Bioceltix | 504.27M |